There is a growing expectation worldwide for transparency into how the life sciences industry conducts business with healthcare providers. In recent years, a major focus for public interest groups, legislators, and now enforcement bodies, has been to "shine a light” on the financial relationships between these companies and doctors. While this trend started in the United States, it has spread globally, with each geographic region putting its own requirements on who is considered a covered recipient and what is reportable. Additionally, with regulations such as the EU GDPR that challenges the fundamental concept of transparency, this has left many companies confused as they try to decipher the multitude of evolving rules and steer their way through the challenging waters of global business and regulations.
Navigate through the countries below to learn more about the different laws and codes.